Monoamine Metabolism in Pregnancy
There has been much speculation in recent years suggesting that the biologically active monoamines play a part in the mechanisms of pregnancy and labour (British Medical Journal 1964) , but there is little direct evidence to indicate that their role is a central one. When this study began, in 1958, there were three pieces of information which appeared to establish a prima facie case for further investigation:
(1) Astrom & Samelius (1957) had shown that the placental vasculature was extremely sensitive to the vasoconstrictor action of 5-hydroxytryptamine (5-HT). This observation has since been amply confirmed (Gautieri & Ciuchta 1962 , Goerke et al. 1961 , Panigel 1962 ).
(2) There was also evidence, repeatedly confirmed, that 5-HT injection into the motherin pharmacological dosage at leastkills the fketus (Correll et al. 1952 , Page & Glendening 1955 , Waugh & Pearl 1960 . Tryptamine, though not tyramine, appears to have a similar though milder action (Quigley 1965) . This phenomenon probably stems from the effect of 5-HT on the placenta rather than from any direct toxic action on the foetus (Robson & Senior 1964 , Fahim et al. 1966 .
(3) Both Luschinsky & Singher (1948) and Thompson & Tickner (1949) had demonstrated the presence of a high concentration of monoamine oxidase (MAO) in human placenta. This enzyme is widely believed to be of major importance in the inactivation of biologically active monoamines (Blaschko 1952 , Davison 1958 , Kopin 1964 . Whilst its presence in placenta may be a biochemical atavism, it is reasonable to suppose that it is there to safeguard the feetal oxygen supply against amine vasoconstriction.
The most important stable metabolite of an amine substrate of MAO is its homologous acid, which is excreted in the urine in considerably higher concentration than the parent amine. Urinary output of the acid is therefore usually considered to be a more accurate index of amine production than actual excretion of the amine itself. The major metabolite of 5-HT in particular, 5-hydroxyindoleacetic acid (5-HIAA), has been the object of close study in both normal and pathological human pregnancy (Berry & Hughes 1959 , Bettendorf et al. 1959 , Carter et al. 1962 , Israel et al. 1959 , Koren et al. 1961 , Koren et al. 1963 , Parikh & Bellare 1962 , Periti et al. 1963 , Pigeaud et al. 1958 , Pigeaud et al. 1960 , Sadowsky et al. 1963 , Sauramo et al. 1960 , Vanden Driessche & Delhaye 1963 , although 4-hydroxy-3-methoxymandelic acid (VMA), quantitatively the most important metabolite of adrenaline and noradrenaline, has also received its share of interest (Caderas de Kerleau et al. 1965 , Cession 1964 , Periti, Gasparri, Battaglia & Santini 1963 . It would be fair to say that the results of these investigations are highly inconclusive; they show a surprising diversity and no clear pattern emerges. Whilst the assay procedures are relatively straightforward (Sandler 1963 , Ruthven 1963 ) their performance tends to demand a certain degree of expertise! A careful prospective investigation therefore appeared to be indicated. My colleagues and I (Sandler, Ruthven & Cornwell 1966, in preparation) collected twenty-four-hour urine samples at monthly intervals during pregnancy from 23 women, of whom 4 subsequently developed toxaemia of pregnancy. The following measurements were recorded on each sample: 5-HT and 5-HIAA; tryptamine and its metabolite, indoleacetic acid; tyramine; VMA; homovanillic acid (dopamine metabolite); volume. These data were fed into a computer and a number of questions were asked. It emerged that the output of each was constant throughout pregnancy, with the exception of tryptamine, whose excretion underwent a gradual but slight rise. Whilst the number of toxaemics was small, their excretion values did not appear to differ from those of patients whose pregnancy was uncomplicated.
Urinary amines such as tryptamine are likely to derive mainly from direct renal decarboxylation of their amino-acid precursor (Brengelmann et al. 1958 , Sandler & Snow 1958 . Thus, the present finding may represent an adaptive increase of I-aromatic amino-acid decarboxylase to pregnancy, somewhat similar to the increase of histidine decarboxylase observed during mouse pregnancy (Rosengren & Steinhardt 1961) . Although these tryptamine levels are at variance with those reported by , they agree well with a previous finding of the present author (Sandler & Baldock 1963) during an investigation of MAO activity in human pregnancy.
In 1949, Thompson & Tickner showed that placental MAO is sensitive to low oxygen tension and suggested that enzyme activity might be decreased in toxemia of pregnancy, which is known to be associated with placental hypoxia (for references see Sandler & Coveney 1962a) . Although a number of attempts had failed to demonstrate this association (Luschinsky 1950 , Lindberg & Westling 1962 , Klinge et al. 1964 , perhaps because of methodological shortcomings (Sandler & Coveney 1962b) , Sandler & Coveney (1962a) were able to show a highly significant decrease of MAO activity in toxemic placenta compared with normals; the greater the severity of the toxaemic process, the more pronounced was the enzyme deficit. De Maria (1964) has confirmed this finding.
The present-day view of toxvmia in most popular currency, whilst not accounting completely for its occasional onset after delivery, is that a pressor substance liberated from the toxaemic placenta is responsible for the clinical features. One such putative pressor substance, 'hysterotonin', was described by Hunter & Howard (1960 . A more likely candidate is renin whose presence has also been noted in placenta (Gross et al. 1964 ) although there does not appear to be any untoward rise in circulating levels in toxemia (Brown et al. 1965) . Sandler & Coveney (1962a) viewed the MAO deficit which they noted in toxxemia as part of a trigger mechanism leading to a 'Goldblatt' placenta, by analogy with the well-known ischoemic kidney preparation (Goldblatt et al. 1934) . A small decrease in enzyme activity might lead to a build up of vasoactive amines such as 5-HT, with subsequent vasoconstriction, giving rise to hypoxia and further functional MAO inactivation. Thus a vicious circle mechanism would be set up whereby a minor degree of enzyme deficit might lead to profound placental hypoxia.
A hypothesis is as good as the experiments designed to test it. If the vicious circle hypothesis were correct, there would be a number of experimental implications:
(1) A decrease of MAO would give rise to an elevation of placental amine levels. Senior et al. (1963) have, in fact, noted increased concentrations of 5-HT in toxaemic placenta although their observations could not be confirmed by Klinge et al. (1964) . The findings of Senior et al. and indeed the whole vicious circle hypothesis, require the presence of the 5-HT-forming enzyme, I-aromatic amino-acid decarboxylase, in placenta. Although this has been identified in certain animal placentae (Pepeu & Giarmann 1962) , it had never been detected in human placenta (Page 1945) until recently, when Sandler, Panigel & Contractor (1966, in preparation) demonstrated trace amounts by sensitive radioisotopic perfusion procedures. The promising preliminary experiments of Hans & Kopelman (1964) involving the administration of a decarboxylase inhibitor in toxwemia, although not altogether borne out by Kincaid-Smith et al. (1966) , are a possible pointer to future therapy when more potent inhibitors than methyldopa become available. A small alteration in 5-HT metabolism is not likely to reveal itself in a large pool so that the apparently unchanged 5-HIAA output noted earlier (Sandler, Ruthven & Cornwell 1966, in preparation) in toxaemia need not affect the validity of the hypothesis.
(2) Although early attempts to produce a chronic ischxmic placental preparation in the experimental animal had not proved practicable (Ogden et al. 1940 , Bastiaanse & Mastboom 1949 ), Berger and his colleagues (Berger & Boucek 1964) and Kumar (1962) succeeded, and were able to induce, in the rabbit and dog respectively, a hypertension-proteinuria syndrome comparable in many respects to human toxaemia. Similar experiments in primates are awaited with interest.
(3) If the MAO defect is the primary lesion, it will either be localized to the placenta or widespread throughout the body. A generalized defect may well stem from a dietary source. At least one item of diet, nutmeg, is known to contain an MAO-inhibitory principle (Truitt et al. 1963) and it is likely that there are many similar foodstuffs, Section ofExperimental Medicine and Therapeutics 743 as yet undetected. Such an explanation might go far to explain the puzzling geographical distribution of toxemia (Dieckmann 1952) .
Alternatively, an MAO inhibitor may derive from an altered gut flora. Phillips et al. (1962) have shown that the livers of germ-free chicks contain higher concentrations of MAO than controls, whilst Brewer (1962) has indicated that gut sterilization may exert a beneficial effect on the toxemic patient. Sandler & Baldock (1963) tried to determine experimentally whether a generalized MAO defect was present in toxwemia. Although the oral 5-HT metabolism test (Sjoerdsma, Gillespie & Udenfriend 1958 gave evidence of MAO inhibition, this finding was not confirmed by the tryptamine excretion test (Sjoerdsma, Oates, Zaltzman & Udenfriend 1959) . The final answer to the problem must await the advent of a more satisfactory in vivo test of enzyme function.
If the vicious circle hypothesis were correct, administration of an MAO inhibitor to a healthy pregnant woman might be expected to precipitate a toxemic state. This is not the case (Dally 1960 , Barron 1962 , Stein & Paxson 1963 , although it is possible that the drugs do not cross the placental barrier. The patients in Barron's and in Stein & Paxson's series, however, were only given the inhibitors in late pregnancy. Even so, careful scrutiny of their papers would appear to indicate that there may have been a marginal increase in the incidence of toxemia in the treated groups compared with controls. It may well be that the time of onset of the MAO defect is crucial. Cliff & Reynolds (1959) found that an injection of adrenaline at about the 22nd day of pregnancy in the rabbit would result in undersized non-macerated stillborn feotuses at term; this effect could not be produced by injection on the 21st or 24th day of pregnancy. Franklin & Brent (1964) have stressed that the growthretarding effect of uterine vascular clamping on the rat foetus depends on time of application.
There is thus much that is suggestive but few firm data to implicate an abnormal metabolism of monoamines in the toxeemic process or, indeed, in the physiology of pregnancy in general. Nevertheless we have so little information about these mechanisms that it would appear unwise to ignore even such tenuous leads as those presented here.
Professor J M Robson and Mr F M Sullivan (Pharmacology Department, Guy's Hospital Medical School, London)
5-Hydroxytryptamine, Placental Function and Tox;emia of Pregnancy
In the last decade or so tremendous advances have been made in our knowledge of the function of various amines, their distribution in the body and the effect of drugs on body amines. The knowledge has revolutionized research on brain function and has led to results which not so long ago seemed unattainable. It has also led to a much better understanding of peripheral adrenergic mechanisms and to the development of new drugs for the treatment of hypertension and other conditions. The study of amines in the central nervous system is beginning to shed some light on the control of the sexual and reproductive systems by the brain but this aspect of the work is not under discussion here. We are concerned with the role of amines in reproduction and particularly in placental function in relation to normal and abnormal pregnancy.
We shall be dealing with the experiments we have done to study the effects of 5-hydroxytryptamine (5-HT, serotonin) on placental function and the effects of this on the foetus, and we shall also mention some work with adrenaline since this amine has produced rather similar effects, though its mechanism of action may be rather different.
Most experiments have been done on mice but some of the important effects have also been obtained on rats and rabbits.
Lethal Effects ofS-HTon the Fatus
In the initial experiments done some years ago we observed that a single injection of 5-HT creatinine sulphate subcutaneously into pregnant mice rapidly led to death of the foetusesmost of them being dead within half an hour, and with no obvious toxic effects on the mother at all (Poulson et al. 1960) . When these animals were examined two or more hours after the injection it was found that the placente were abnormal, and by twentyfour hours they were usually hemorrhagic and on histological examination showed large areas of necrosis. If examined immediately after feetal death, however, many placenta were histologically normal or showed only minimal changes, namely, engorgement and nuclear fragmentation.
There is evidence that the placental damage may have been secondary to the death of the foetus. This was investigated by mechanically killing foetuses in utero or by removing feetuses after tying the cord. The placentee were left in situ and removed twenty-four hours later. It was then found that these placenta were also hemorrhagic and contained areas of necrosis, giving a picture very similar to, if not identical with, that seen after the administration of 5-HT (Lindsay et al. 1963) .
It thus seems that immediately after the administration of 5-HT, functional changes may occur in the placenta in the absence of any gross histological effects. These subtle changes in placental function are nevertheless sufficient to lead to death of the foetus. This must be true unless there is some other explanation for the lethal effect of 5-HT on the foetus. We shall only briefly mention the main possibilities here since they are discussed in detail elsewhere (Robson & Sullivan 1966) . It has been
